These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20803011)

  • 1. Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo.
    Wang XJ; Gu K; Xu JS; Li MH; Cao RY; Wu J; Li TM; Liu JJ
    Cancer Immunol Immunother; 2010 Dec; 59(12):1859-66. PubMed ID: 20803011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65.
    Zhang Y; Xu J; Zhao R; Liu J; Wu J
    Vaccine; 2007 Sep; 25(39-40):6911-21. PubMed ID: 17728021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
    Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
    Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.
    Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H; Roque RS
    Vaccine; 2005 Sep; 23(40):4834-43. PubMed ID: 15996796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts.
    Jacobs E; Watson SA; Michaeli D; Ellis IO; Robertson JF
    Br J Cancer; 1999 May; 80(3-4):352-9. PubMed ID: 10408837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
    Wang XY; Li Y; Manjili MH; Repasky EA; Pardoll DM; Subjeck JR
    Cancer Immunol Immunother; 2002 Aug; 51(6):311-9. PubMed ID: 12111119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
    Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
    Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
    Ren W; Strube R; Zhang X; Chen SY; Huang XF
    Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.
    Dong B; Sun L; Wu X; Zhang P; Wang L; Wei H; Zhou L; Hu X; Yu Y; Hua S; Wang L
    Cancer Immunol Immunother; 2010 Jun; 59(6):899-908. PubMed ID: 20087582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis.
    Thompson SJ; Francis JN; Siew LK; Webb GR; Jenner PJ; Colston MJ; Elson CJ
    J Immunol; 1998 May; 160(9):4628-34. PubMed ID: 9574571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis.
    Beech JT; Siew LK; Ghoraishian M; Stasiuk LM; Elson CJ; Thompson SJ
    J Immunol; 1997 Oct; 159(8):3692-7. PubMed ID: 9378954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cells expressing a recall antigen are powerful cancer vaccines.
    Schweighoffer T
    Eur J Immunol; 1996 Nov; 26(11):2559-64. PubMed ID: 8921939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor.
    Tegerstedt K; Franzén A; Ramqvist T; Dalianis T
    Cancer Immunol Immunother; 2007 Sep; 56(9):1335-44. PubMed ID: 17268793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a potent DNA vaccine targeting B-cell epitopes of hGRP induces prophylactic and therapeutic antitumor activity in vivo.
    Yong L; Huiyong Z; Jing H; Huaqian W; Xiangbing H; Yanjun M; Xiaoyu G; Li H; Yanan Y; Rongyue C; Hao F; Jingjing L; Jie W
    Gene Ther; 2010 Apr; 17(4):459-68. PubMed ID: 20130655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
    Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yankai Z; Rong Y; Yi H; Wentao L; Rongyue C; Ming Y; Taiming L; Jingjing L; Jie W
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1365-71. PubMed ID: 16725110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma.
    Xiangbing H; Yankai Z; Ming L; Yong L; Yu Z; Huiyong Z; Yingying C; Jing H; Yun X; Liang J; Rongyue C; Jingjing L
    Int Immunopharmacol; 2010 Feb; 10(2):230-8. PubMed ID: 19913113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.